ArticleJournal of Cancer2024

Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study.

Qiang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.